The Medefil Story
Medefil, Inc. was incorporated in 1998 with the focus on addressing the unmet need in the saline and heparin flush injectable products. Medefil’s commitment to providing high quality, cost-effective sterile pharmaceutical products leading us to installing two state of the art automated syringe manufacturing lines. To-date Medefil has supplied over one Billion sterile prefilled syringe products through these automated syringe lines.
After spending over 15 years gaining and establishing manufacturing excellence, a decision was made to move into formulation and development of injectable products. Medefil has now established a state of the art R&D lab with capability of developing injectable products and are now installing additional manufacturing lines that will give us the ability to supply high quality cost effective injectable products.
We are a specialty pharmaceutical company dedicated to improving patient safety and quality of life by developing and manufacturing high-quality and affordable injectable products that fulfill a critical unmet market need.
Medefil strives to identify critical unmet needs in medication delivery and resolve them.
Our Business Model
Medefil is growing as a fully integrated specialty pharmaceutical company. At Medefil our goal is to develop and manufacture injectable products where quality and supply reliability are crucial, and safety and ease-of use are of utmost importance.
Medefil is committed to building a diversified pipeline that aligns with Medefil’s philosophy for success:
Injectable with shortage and supply issues
Difficulty to develop and manufacture injectable products
Enhancement of injectable product to create value at the point of care